ACCIÓ’s Noves Oportunitats de Negoci calls for proposals provide Catalan companies with a supportive framework for analysing and structuring new growth opportunities.
Read moreGENESIS Biomed ha lanzado el programa GENESIS CEO Academy, una iniciativa formativa diseñada para preparar a los líderes del futuro en el ámbito de las ciencias de la vida. Este programa está orie...
Read moreJoan Martí: “Corporate culture is a critical factor in M&A and partnership processes.”
Read moreRising life expectancy and increasing pressure on healthcare and social systems are driving a new market focused on prevention, independence, and quality of life for older adults.
Read moreRubén Pérez-Mañanes: “A public hospital can sustain a regulated, multidisciplinary and scientifically productive manufacturing unit without compromising its healthcare mission”
Read moreInnovation in healthcare does not arise solely from good ideas, but from an institutional architecture capable of attracting talent, coordinating capabilities and accelerating translation
Read moreThe event brought together experts from hospitals, research organizations, industry and innovation ecosystems to co-create sustainable service models for the Paediatric Health Data Space (PHDS).
Read moreJosep Samitier: “It’s key to strengthen public-private collaboration and attract venture capital to promote emerging projects that will allow us to consolidate technological and productive capacit...
Read moreThe conference was organised by the UAI (Innovation Support Unit) of the IiSGM (Gregorio Marañón Health Research Institute) and was sponsored by GENESIS Biomed, HOFFMANN EITLE, DINAMIZA Health Resea...
Read moreDigital twins make it possible to simulate personalised clinical scenarios without intervening directly on the patient, reducing uncertainty in decision-making.
Read moreGENESIS Biomed closes 2025 as its best year ever, with strong growth compared to 2024: 506 projects (+26.5%) and 323 customers (+43.6%).
Read moreDigital transformation and artificial intelligence are redefining the traditional model of clinical trials.
Read more